Video

Dr. Jain on Results of Gender Disparities Study in Oncology

Author(s):

Shikha Jain, MD, hematologist/oncologist, Rush University Medical Center, discusses the disparities between male and female professionals at medical conferences, specifically the American Society of Clinical Oncology (ASCO) Annual Meeting.

Shikha Jain, MD, hematologist/oncologist, Rush University Medical Center, discusses results of a study that explored the disparities between male and female professionals at medical conferences.

According to data pulled from the 2017 and 2018 ASCO Annual Meetings, female speakers were less likely to receive a professional introduction compared with male speakers (61% versus 81%). Many females were introduced by their first name only compared with male speakers (17% vs 3%). Specifically, male introducers were more likely to address female speakers by their first name compared with female introducers (24% vs 7%).

Not receiving a professional introduction contributes to the unconscious bias of attendees because it makes the person appear less qualified than their colleagues, Jain explains. This research is important, she says, because when more women are seen in leadership positions, it improves the role of females in healthcare.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD